Medicare copays for new Alzheimer's drug could reach $11,500

WASHINGTON (AP) — A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, ... Read More

Alzheimer’s Drugs Are Finally Tackling the Disease Itself. Here’s How

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 clinical trials, offer new hope ... Read More

Medicare Part D to Cap Annual Drug Costs at $2,100 in 2026

In a significant move to ease the financial strain on seniors, Medicare Part D will implement a new rule in 2026, capping annual out-of-pocket drug costs at $2,100. This initiative, part of the ... Read More

Controversial New Alzheimer’s Drugs Offer Hope—But at a High Cost

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, including brain bleeds and strokelike symptoms ... Read More